In a phase I study using a dendritic cell containing neoantigens with high binding affinity for HLA-A2, vaccination resulted in expansion of CD8+ T cells specific to about half of the immunogenic peptides.53 Anti-tumor activity was not assessed. The gene discussed is CD8A; the disease is neoplasm.